Publications Categories: Neurodevelopmental Disorders

CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for SYNGAP1-related intellectual disability.

CRISPR-mediated transcriptional activation as a mutation-independent therapeutic strategy for SYNGAP1-related intellectual disability. Sichlinger L, Reilly MB, Arora S, Zhang S, Marotta N, Rodríguez-Acevedo KL, Hooks M, Czarnecki KS, Winter JJ, Waxman EA, Dungan LV, Hong I, Araki Y, Johnson R, Huganir RL, Pavani G, French DL, Davidson BL, Prosser BL, Heller EA. bioRxiv [Preprint]. 2025 […]

Clinical signatures of SYNGAP1-related disorders through data integration.

Clinical signatures of SYNGAP1-related disorders through data integration. McKee JL, Magielski JH, Xian J, Cohen S, Toib J, Harrison A, Chen C, Kim D, Rathod A, Brimble E, Fitter N, Graglia JM, Helde KA, McKeown Ruggiero S, Boland MJ, Prosser BL, Sederman R, Helbig I. Genet Med. 2025 Jun;27(6):101419. https://doi.org/10.1016/j.gim.2025.101419. PMID: 40119723. PMCID: PMC12419475.

Translatable electrophysiological and behavioral abnormalities in a humanized model of SYNGAP1-disorder.

Translatable electrophysiological and behavioral abnormalities in a humanized model of SYNGAP1-disorder. Felix AJ, Brown, BL, Marotta N, Gessner, MJ, Houserova, M, Huerta-Ocampo I, Wilson T, Randell R, Dawicki-McKenna JM, Reinhardt D, Uchida K, McSalley I, McKee JL, Helbig I, Boland MJ, Davidson BL, Prosser BL. bioRxiv. 2024 August 22 (updated 2025 November 8). doi:10.1101/2024.08.22.609238v3.

Delineating clinical and developmental outcomes in STXBP1 -related disorders.

Delineating clinical and developmental outcomes in STXBP1-related disorders. Xian J, Thalwitzer KM, McKee J, Sullivan KR, Brimble E, Fitch E, Toib J, Kaufman MC, deCampo D, Cunningham K, Pierce SR, Goss J, Son Rigby C, Syrbe S, Boland M, Prosser B, Fitter N, Ruggiero SM, Helbig I. Brain. 2023 Dec 1;146(12):5182-5197. PMID: 38015929. doi: 10.1093/brain/awad287.